GenomicsGastroenterologyPeer-reviewed
HLA-DQA1*05 is associated with the development of antibodies to anti-TNF therapy
Aleksejs Sazonovs, Nicholas Alexander Kennedy, Loukas Moutsianas…·Thankam Paul
This study identifies HLA-DQA1*05 as a genetic risk factor for anti-drug antibody development in Crohn's disease patients treated with anti-TNF therapies.
424 citationstop 1%